Print

BioCurex Inc. (BOCX) Announces Commercial Launch of Its RECAF Blood Test to Detect Cancer in Dogs  
9/30/2010 9:59:53 AM

RICHMOND, British Columbia, Sept. 30, 2010 (GLOBE NEWSWIRE) -- BioCurex Inc. (OTCBB:BOCX) announced the commercial launch of its RECAF blood test for cancer in dogs through its wholly owned subsidiary, OncoPet Diagnostics.
//-->